You can buy or sell Fluidigm and other stocks, options, ETFs, and crypto commission-free!
Fluidigm Corp. engages in the manufacture and marketing of innovative technologies and tools for life sciences research. It sells instruments and consumables, including integrated fluidic circuits; assays and reagents to academic institutions; clinical research laboratories, and biopharmaceutical; agricultural biotechnology; and companies and contract research organizations. Read More The company was founded by Stephen R. Quake & Gajus V. Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.
South San Francisco, California
52 Week High
52 Week Low
Advertising and Marketing
Fluidigm Corp (FLDM) Files 10-K for the Fiscal Year Ended on December 31, 2018
- By insider Fluidigm Corp (FLDM) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Fluidigm Corp creates, manufactures, and markets technologies and life-science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon microfluidics and mass cytometry technologies. Fluidigm Corp has a market cap of $957.620 million; its shares were traded at around $13.81 with and P/S ratio of 4.96. Fluidigm Corp had annua...
Fluidigm files for mixed shelf offering
Fluidigm (NASDAQ:FLDM) has filed a prospectus for an unspecified mixed shelf offering....
Yahoo FinanceMar 15
Fluidigm (FLDM) in Focus: Stock Moves 8% Higher
Fluidigm Corporation FLDM was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 34.2% in the past one-month time frame. The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The rec...
Expected May 2, After Hours